Jacobs Solutions heads into its August 4 earnings date with the stock up 6% over the past month and options traders unusually bullish — a setup that contrasts with a modest short position that has barely moved.
The most striking signal in positioning is options. Call-side demand has overwhelmed puts, with the put/call ratio running at just 0.17 — well below its 20-day average of 0.24 and near the lowest reading of the past year (the 52-week low is 0.12). That's a sharp reversal from late May and early June, when the PCR was above 0.60 for weeks. Something shifted in mid-June: as the stock recovered, protective hedging gave way to outright call buying. The borrow side tells a much quieter story. Short interest has barely changed, hovering around 5.8% of free float — roughly where it has been for months. Availability remains extremely loose at over 1,000%, meaning there is roughly ten times more stock available to borrow than is currently being shorted. Cost to borrow is a negligible 0.41%, down slightly on the week. There is no squeeze dynamic here, no meaningful borrow pressure, and no sign of short sellers adding conviction.
The Street sits in a broadly constructive but cautious place. Most analysts carry positive ratings — Citi has a Buy with a $181 target, RBC an Outperform at $169, and Goldman initiated coverage last November at Buy with a $158 target — but the mean target of roughly $157 implies about 20% upside from the current $130. The most recent move, from Truist this week, was a $1 trim to $149 while keeping a Hold — barely a signal at all. After the Q2 print in May, Wells Fargo cut its target from $137 to $131 (Equal-Weight), landing almost exactly on the current price. The forward EPS momentum score ranks in the 90th percentile on a 12-month basis, which is the standout factor. Near-term momentum scores are weaker — the 30-day EPS momentum rank is just 27 — suggesting the longer-term growth story is intact but recent revisions have been soft. The EV/EBITDA multiple is running at about 11.4x, down modestly over the past month, while PE sits near 15.7x. Neither is stretched for an engineering services name with infrastructure tailwinds.
The insider picture adds a layer of interest. The CEO, Bob Pragada, bought 3,601 shares at $111 in mid-May — a $400K open-market purchase made when the stock was near its recent lows. A director also added shares across two transactions in May at similar levels. Against that, the CFO sold a small block in early June at $121. Net insider activity over the past 90 days is positive: roughly 7,500 net shares bought for just under $900K in value. The CEO purchase in particular is the more meaningful signal — it came at the depths of the post-earnings selloff, when the stock had fallen 13% over five days after the Q2 report.
That post-earnings drop is worth keeping in mind. The May 5 print triggered a 3% next-day fall and a 13% five-day drawdown — the kind of reaction that explains why the PCR was elevated through most of May and June. Peer KBR is up nearly 9% on the week, and LDOS has added 8%, suggesting government services and engineering names more broadly have caught a bid. Jacobs' 3.4% weekly gain tracks that move without leading it.
The next test is August 4. With the CEO having bought aggressively at $111 and the stock now 17% higher, and with call buyers now dominant in the options market, the focus will be on whether the guidance revisions flagged after May's print have stabilised — and whether management's long-term infrastructure and life sciences growth narrative can withstand another close look.
See the live data behind this article on ORTEX.
Open J on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
